Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report 2026: Capitalize on the $18 Billion 2032 Market with Agilent, Bruker Daltonics, Dassault Systemes, and Illumina

globenewswire.com

Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report 2026: Capitalize on the $18 Billion 2032 Market with Agilent, Bruker Daltonics, Dassault Systemes, and Illumina Dublin, Nov. 09, 2026 (GLOBE NEWSWIRE) -- "Structural Biology and Molecular Modeling Techniques - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global structural biology and molecular modeling techniques market was valued at US$5.9 billion in 2025 and is projected to reach US$18 billion by 2032, expanding at a compound annual growth rate (CAGR) of 17.3%. Market growth is being supported by rising demand for targeted drug discovery, precision medicine, protein engineering and advanced disease research.

Structural Biology and Molecular Modeling Market Trends

Structural biology and molecular modeling technologies are increasingly central to pharmaceutical and biotechnology research. X-ray crystallography, nuclear magnetic resonance spectroscopy, cryo-electron microscopy (cryo-EM) and computational modeling provide the molecular insights required to identify therapeutic targets, analyze binding sites and optimize drug candidates.

X-ray crystallography currently accounts for a leading market position because of its established role in high-resolution biomolecular analysis. Cryo-EM is also gaining prominence as improvements in imaging resolution and analytical workflows expand its use across complex proteins and molecular assemblies. At the same time, faster computing infrastructure, machine learning algorithms and sophisticated visualization platforms are improving the speed and accuracy of computational modeling.

Drug Discovery and Life Sciences Applications

Drug discovery represents a major application segment, driven by the need to develop more selective and effective therapies. Structural analysis enables rational drug design and structure-based optimization, while computational modeling supports predictions of drug-target interactions and the assessment of molecular modifications before laboratory testing.

Protein engineering is another important growth area. Modeling platforms help researchers modify proteins and enzymes to improve stability, activity and specificity, supporting the development of biopharmaceuticals and industrial enzymes. Structural biology also contributes to genomics and disease research by revealing how genetic mutations affect protein structure and function, strengthening the foundation for personalized therapies.

Pharmaceutical companies remain leading end users due to substantial investment in novel therapeutics and accelerated development programs. Biotechnology companies, academic institutions and research institutes also represent significant sources of demand, particularly as collaborative research initiatives and public funding expand access to advanced analytical tools.

Key Market Growth Drivers

Market Segment and Regional Outlook

The report analyzes the structural biology and molecular modeling techniques market by tool category, including SaaS and standalone modeling, databases, visualization and analysis solutions, and other tools. The SaaS and standalone modeling segment is forecast to reach US$10.6 billion by 2032, growing at a CAGR of 18.3%. The databases segment is projected to expand at a CAGR of 15.5% during the analysis period.

Geographic coverage includes the United States, Canada, Japan, China, Europe, Asia-Pacific, Latin America, the Middle East and Africa. The U.S. market was valued at US$1.6 billion in 2025. China is expected to record a CAGR of 22.4%, reaching approximately US$4.1 billion by 2032. The analysis also examines growth patterns in Japan, Canada, Germany and other major regional markets.

Report Scope and Strategic Value

The report provides independent analysis of annual sales and market forecasts from 2025 through 2032. It assesses market opportunities, competitive dynamics, technology adoption, regional performance and the factors likely to influence future demand. Strategic insights help organizations evaluate revenue opportunities, prioritize investments and anticipate changes in the global structural biology and molecular modeling competitive landscape.

Key questions addressed include:

Featured Companies

Domain Expert Insights

The analysis incorporates perspectives from domain experts across industry, enterprise and academia, adding context beyond conventional secondary research. The report tracks early market signals emerging from expert discussions, company activity, conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports and institutional publications.

These inputs are synthesized to identify strategic market direction, evolving technology priorities and developments with the potential to affect investment and competition. Company-level intelligence complements the broader market assessment, while regional market share analysis is included where competitive structures and geographic dynamics warrant additional detail.

Report Features

Key Attributes

For more information about this report visit https://www.researchandmarkets.com/r/9xomm7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.